PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Hyperion DeFi, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Hyperion DeFi, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Assets Ratio: Of every $100 the company owns, $29 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 93% of Healthcare companies in United States.
  • Shareholder Slice Ratio: Share count rose 1,794% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 92% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.

Where $100 of sales goes

$2,433Operating costs$192Interest$5,571Net loss$110Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-0.9×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Higher than 61% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 85% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Data incomplete

Asset Productivity Ratio

—

Data incomplete

Balance-sheet strength

Debt Due Cover Ratio

-28.8×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 63% of Healthcare companies in United States.

Cash Cushion Ratio

−5%

Debt, after subtracting cash, equals 5% of its market value (net debt).

Lower than 74% of Healthcare companies in United States.

Tangible Assets Ratio

29%

Of every $100 the company owns, $29 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 93% of Healthcare companies in United States.

Tangible Net Worth Ratio

10%

Of every $100 of net worth, $10 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 69% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+1,794%

Share count rose 1,794% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 92% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Hyperion DeFi, Inc. made a loss over the last year. Hyperion DeFi, Inc. owes $0.10 for every $1 it owns. Hyperion DeFi, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Hyperion DeFi, Inc. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

0.44

The share price is 0.44 times Hyperion DeFi, Inc.'s book value per share, lower than 93% of Healthcare companies in United States.

Market cap

$44 M

The total market value of all of Hyperion DeFi, Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.

Net worth (book value)

$102 M

What Hyperion DeFi, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$6.71

Net worth divided by the number of shares. The share price of $2.92 is 0.4 times this, which is the P/B above.

Return on equity (ROE)

9.6%

Hyperion DeFi, Inc. earned 9.6% on its shareholders' money over the last year, higher than 83% of Healthcare companies in United States.

Owes vs Owns

0.10×

Hyperion DeFi, Inc. owes $0.10 for every $1 it owns (low), lower than 87% of Healthcare companies in United States.

Dividend yield

None

Hyperion DeFi, Inc. does not currently pay a dividend.

Revenue growth

+1319%

Revenue rose 1319% in the year to Dec 2025.

Profit growth

Loss

Hyperion DeFi, Inc. made a loss in each of the last two years.

Profit margin

-5570.6%

Hyperion DeFi, Inc. lost $5571 for every $100 of revenue.

Interest cover

Not covered

Hyperion DeFi, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net debt

Hyperion DeFi, Inc. had $2 M more debt than cash (net debt) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Hyperion DeFi, Inc.: $44 M ÷ $102 M (30 Jun 2026) = 0.4.

What is Hyperion DeFi, Inc.'s return on equity?

Hyperion DeFi, Inc. earned 9.6% on its shareholders' money over the last year, higher than 83% of Healthcare companies in United States.

How much does Hyperion DeFi, Inc. owe compared with what it owns?

Hyperion DeFi, Inc. owes $0.10 for every $1 it owns (low), lower than 87% of Healthcare companies in United States.

Does Hyperion DeFi, Inc. pay a dividend?

No. Hyperion DeFi, Inc. does not currently pay a dividend.

Is Hyperion DeFi, Inc.'s revenue growing?

Revenue rose 1319% in the year to Dec 2025.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.